IN THE SPOTLIGHT

Medscape Onsite: Riding the Wave of NSCLC Updates From San Diego

Medscape Onsite: Riding the Wave of NSCLC Updates From San Diego

Evaluating Immunotherapy as Systemic Therapy Plus RT in Early-Stage NSCLC

Evaluating Immunotherapy as Systemic Therapy Plus RT in Early-Stage NSCLC

Neoadjuvant Chemoimmunotherapy for Resectable NSCLC

Neoadjuvant Chemoimmunotherapy for Resectable NSCLC

FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC

FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC

BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval

BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval

Nivolumab NSCLC Approval Expanded to Perioperative Setting

Nivolumab NSCLC Approval Expanded to Perioperative Setting

Wearable Tied to Better Physical Activity Recovery Following Lung Cancer Surgery

Wearable Tied to Better Physical Activity Recovery Following Lung Cancer Surgery

10 Commonly Asked Lung Cancer Questions With Dr. Jyoti Malhotra

10 Commonly Asked Lung Cancer Questions With Dr. Jyoti Malhotra

Ponsegromab Could Offer Further Treatment for Cancer Cachexia

Ponsegromab Could Offer Further Treatment for Cancer Cachexia

ADCs, Bispecifics and Radiopharma Take Center Stage at ESMO24

ADCs, Bispecifics and Radiopharma Take Center Stage at ESMO24